Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Arthur S. LeibowitzDirector | Organogenesis HoldingsORGO | Open-market buy | 03/09 | 03/11 | 5,000 sh | $2.68 | $13,400 | +1.7% |
Michael Joseph DriscollDirector | Organogenesis HoldingsORGO | Open-market buy | 03/09 | 03/11 | 10,000 sh | $2.67 | $26,700 | +4.6% |
Glenn H. NussdorfDirector | Organogenesis HoldingsORGO | Open-market sale | 25/12/16 | 25/12/18 | 200,000 sh | $5.14 | $1,028,000 | −7.2% |
Organogenesis HoldingsORGO | Open-market sale | 25/11/24–25/11/26 | 25/11/26 | 300,000 sh3 trades | $5.31avg. | $1,592,120.43 | −9.8% | |
Organogenesis HoldingsORGO | Open-market sale | 25/06/09–25/06/10 | 25/11/03 | 22,776 sh2 trades | $3.55avg. | $80,833.2 | −6.4% | |
Organogenesis HoldingsORGO | Open-market buy | 25/05/14–25/05/15 | 25/11/03 | 358,495 sh2 trades | $3.06avg. | $1,097,000.15 | No record | |
Organogenesis HoldingsORGO | Open-market buy | 25/06/04–25/06/06 | 25/06/06 | 252,264 sh3 trades | $2.88avg. | $725,732.33 | +42.5% | |
Michael Joseph DriscollDirector | Organogenesis HoldingsORGO | Open-market sale | 25/03/04 | 25/03/06 | 25,000 sh | $5.10 | $127,500 | −13.0% |
Organogenesis HoldingsORGO | Open-market sale | 24/12/13–24/12/16 | 24/12/16 | 61,200 sh2 trades | $3.37avg. | $206,358.05 | −2.0% | |
Organogenesis HoldingsORGO | Open-market sale | 24/12/10–24/12/12 | 24/12/12 | 259,332 sh3 trades | $3.62avg. | $940,066.17 | −7.7% | |
Organogenesis HoldingsORGO | Open-market sale | 24/12/06–24/12/09 | 24/12/09 | 59,468 sh2 trades | $3.56avg. | $211,721.44 | −1.7% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 431,786 sh4 trades | $4.36avg. | $1,883,669.86 | −0.7% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% | |
Organogenesis HoldingsORGO | Open-market sale | 24/01/09–24/01/10 | 24/01/11 | 215,893 sh2 trades | $4.36avg. | $941,834.93 | −0.4% |